Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children

Abigail S Kane1,2, Brittany P Boribong1,2,3, Maggie Loiselle1,2

  • 1Department of Pediatrics, Massachusetts General Hospital, Boston, MA, United States.

PubMed

Insights

Monocyte anisocytosis, measured by monocyte distribution width (MDW), is a sensitive biomarker for severe COVID-19 in children. This finding aids in early risk assessment for pediatric SARS-CoV-2 infections.

Area of Science:

  • Pediatric Hematology
  • Infectious Diseases
  • COVID-19 Research

Background:

  • Severe COVID-19 in children requires reliable biomarkers for risk assessment.
  • Monocyte signatures are linked to COVID-19 severity in adults.

Purpose of the Study:

  • To investigate if monocyte anisocytosis correlates with COVID-19 severity in children.
  • To identify effective hematologic biomarkers for pediatric COVID-19.

Main Methods:

  • Multicenter retrospective study of 215 children.
  • Quantified monocyte anisocytosis using monocyte distribution width (MDW).
  • Analyzed association between MDW and COVID-19 severity.

Main Results:

  • Monocyte anisocytosis (MDW) increased with COVID-19 severity and hospitalization need.
  • MDW was more sensitive than other inflammatory markers for severe pediatric disease.
  • An MDW threshold of 23 showed sensitivity for severe pediatric COVID-19.

Conclusions:

  • Monocyte anisocytosis reflects inflammatory changes in pediatric COVID-19.
  • MDW is a clinically accessible biomarker for identifying severe COVID-19 in children.
Abstract

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
984
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
350
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
355
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
997